ADIDAS-JAPAN-K.K.
12.5.2016 07:02:34 CEST | Business Wire | Press release
Multi-sports brand, adidas Japan K.K. (head office: Minato-ku, Tokyo; President: Paul Hardisty) has joined with From One Co., Ltd (head office: Chuo-ku, Tokyo; President: Naoto Michigami), operators of soccer information site, SOCCERKING, to bring you the MILANOVATION present campaign, which fans can participate in simply by Tweeting their thoughts on AC Milan. The campaign began on April 25th.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160511006664/en/
MILANOVATION is a bedroom renovation for AC Milan supporters (known as Milanisti.) With kick-offs late at night due to time zone differences, Milanisti living in Japan face the problem of sleeping through matches. We will help them in various ways with a surprise renovation.
• Participation process:
Tweet your thoughts on AC Milan with the
hashtag, #milanovation.
• Campaign period:
April 25 (Mon.) -
May 15 (Sun.), 2016
• Campaign web site: http://milanovation.jp
Items that appear in the MILANOVATION concept movie
(* The
actual renovations provided will be designed with consideration for the
customer's safety, and therefore may differ from those that appear in
the photos.)
- BEAMING BEAR
At first glance it is a cute teddy bear. It has the red and black
striped AC Milan colors.
But when game time comes, lasers linked to
an alarm beam from both eyes!
The red lights, reminiscent of
flares, wake up the Milanisti.
- RISING BED
The bed rises in conjunction with an alarm set for the game's kick-off time. The maximum angle is 70 degrees. No matter how deeply the Milanisti has been sleeping, it invites him over to the sofa before the game starts.
- BEER BAR FRIDGE
This is a red Milanisti design chair. Resting on its luxurious thickness starts up a gimmick installed in the armrest. An ice-cold bottle of beer pops out instantly. The chair has a cold storage function installed.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160511006664/en/
Contact:
Media Inquiries
Campaign Public Relations Office (in the offices of
Initial Co., Ltd.)
Kenta Ishikawa, +81-3-6862-6688
k-ishikawa@vectorinc.co.jp
Fax:
+81-3-5572-6065
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release
Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co
Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release
Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents
Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release
Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and
LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release
The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o
Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 14:00:00 CEST | Press release
Enpatoran could address a significant unmet need in lupus, specifically targeting cutaneous manifestations of the disease, which currently have no approved therapiesFDA's decision was supported by Phase 2 WILLOW study results, which demonstrated meaningful symptoms improvement, particularly among patients with active cutaneous manifestationsEnpatoran's potential to go beyond current treatment standards in lupus prompted FDA´s breakthrough designation, which is designed to expedite drug development and reviewNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manif
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom